Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Clinical trial NCT01437787 · TERMINATED
Trial details
- NCT number
- NCT01437787
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-31
- Primary completion
- 2014-06-30
- Enrollment
- 289
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.